Trial intelligence / Profile preview

Endostatin plus TC in Liver Metastases

NCT01347424Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Jan 2011
Primary completion
May 2014
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), nasopharyngeal carcinoma (NPC), liver metastasis, sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

endostar
03

Conditions

non-small cell lung cancer (NSCLC)nasopharyngeal carcinoma (NPC)liver metastasis

Beyond the preview

Go deeper on NCT01347424.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01347424.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call